Axogen, Inc. (AXGN) Balance Sheet
As of 2026-06-30 (10-Q), Axogen, Inc. (AXGN) reported total assets of $304.9M, total liabilities of $48.6M and shareholders' equity of $256.3M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $94.6M. Long-term debt: $0.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
AXGNAxogen, Inc.Follow AXGN — free
—
Price chart with a free account
- Market cap
- 2.0B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 28 Oct, in 4 days
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 8.2 | 13.9 | 20.1 | 8.2 | 25.9 | 30.0 | 36.5 | 24.3 | 35.7 | 48.8 | 32.8 | 15.3 | 31.0 | 27.6 | 35.5 | 94.6 | |
| Short-term investments | — | — | — | — | — | — | — | 92.3 | 60.8 | 55.2 | 51.3 | 33.5 | 0.0 | 5.9 | 6.0 | 16.8 | |
| Receivables | 0.8 | 1.1 | 1.9 | 2.9 | 4.8 | 8.1 | 11.1 | 15.3 | 16.9 | 17.6 | 18.2 | 22.2 | 25.1 | 24.1 | 26.2 | 34.1 | |
| Inventory | 1.8 | 3.2 | 3.4 | 3.2 | 3.9 | 5.5 | 7.3 | 12.0 | 13.9 | 12.5 | 16.7 | 18.9 | 23.0 | 33.2 | 42.4 | 47.3 | |
| Current assets | 10.9 | 18.3 | 25.7 | 14.4 | 35.1 | 44.0 | 55.7 | 151.0 | 135.0 | 145.3 | 127.0 | 98.1 | 88.0 | 99.2 | 120.4 | 200.4 | |
| Total assets | 12.5 | 20.2 | 27.7 | 16.4 | 36.7 | 46.4 | 58.9 | 160.2 | 154.6 | 201.4 | 208.0 | 195.4 | 196.8 | 203.7 | 221.7 | 304.9 | |
| Current liabilities | 2.0 | 1.5 | 2.1 | 2.4 | 3.7 | 11.1 | 13.7 | 13.0 | 20.9 | 22.8 | 24.3 | 23.8 | 30.4 | 30.6 | 23.6 | 30.4 | |
| Long-term debt | 4.4 | 21.6 | 25.4 | 25.1 | 24.7 | 20.3 | 19.8 | 0.0 | 0.0 | 32.0 | 44.8 | 45.7 | 46.6 | 47.5 | 48.4 | 0.0 | |
| Short-term debt | 0.4 | — | — | — | — | 0.0 | 0.7 | 0.0 | 1.7 | — | — | — | — | — | — | — | |
| Total liabilities | 6.4 | 23.1 | 27.5 | 27.6 | 28.5 | 31.4 | 33.7 | 13.2 | 22.5 | 78.2 | 95.5 | 94.4 | 101.2 | 99.8 | 92.8 | 48.6 | |
| Shareholders' equity | 6.1 | -2.8 | 0.1 | -11.2 | 8.2 | 14.9 | 25.2 | 147.0 | 132.2 | 123.1 | 112.6 | 101.0 | 95.7 | 103.9 | 128.8 | 256.3 |
USD millions · SEC XBRL
Axogen, Inc. — questions
- How much cash does Axogen, Inc. have?
- $94.6M in cash and cash equivalents as of 2026-06-30.
- How much debt does Axogen, Inc. have?
- $0 of long-term debt as of 2026-06-30.
- What are Axogen, Inc.'s total assets?
- $304.9M as of 2026-06-30.
- What is Axogen, Inc.'s shareholders' equity?
- $256.3M as of 2026-06-30.
Every figure on this page comes from Axogen, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.